<DOC>
	<DOCNO>NCT01510418</DOCNO>
	<brief_summary>The goal pilot study understand socialization adult men hemophilia live United States quality life order improve comprehensive care person congenital bleed disorder . Studies Europe suggest despite medical , surgical , biotechnology advance care person congenital bleed disorder hemophilia A B , men hemophilia early work disability health-related low quality life men age hemophilia general population . Congenital bleeding disorder know medical psychosocial impact school also activity , e.g . participation sport begin young age . The psychosocial impact live congenital bleed disorder study describe childhood . The support relationship childhood include parent primary family origin support generally consider pediatric comprehensive care model . Support relationship adulthood well describe study . The role spouse significant others ( SSO ) PWCBD health care interest delivery adult comprehensive care well understand contribution health-related quality life PWCBD . Additionally , study seek learn impact congenital bleeding disorder SSO . The study use self-reported medical social information questionnaire , health-related quality life survey , confidential interview . Results study may guide comprehensive care support provide adult person congenital bleed disorder hemophilia treatment program . This study focus PWCBD hemophilia A B model experience person congenital bleed disorder .</brief_summary>
	<brief_title>Socialization Adult Men With Congenital Hemophilia A B</brief_title>
	<detailed_description>There two group ( cohort ) study . One group adult men congenital hemophilia A B qualify study . The group spouse significant ( SSO ) voluntarily identify person congenital bleeding disorder recruitment study . For adult men congenital hemophilia A B , study involve minimum 2 visit include screening , medical history physical exam review , complete confidential questionnaire interview . Eligible men congenital hemophilia A B ( person congenital bleed disorder , PWCBD ) give option permit investigator contact spouse significant ( SSO ) participation study . If PWCBD SSO , SSO require participate study . Spouse/significant ( SSO ) men congenital hemophilia A B may enter study voluntarily identify partner ( PWCBD ) partner opt allow investigator contact . For SSO choose participate study , study involve minimum one visit include complete confidential questionnaire interview . All participation include questionnaire interview information collect confidential protected health privacy information law record de-identified . The study sponsor grant The National Hemophilia Foundation .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Eligibility criterion person congenital bleeding disorder ( PWCBD , men congenital hemophilia ) : Known diagnosis congenital hemophilia A B without inhibitor ( define plasma factor VIII factor IX level lower limit normal medical history consistent diagnosis ) . Male age 21 year old Willing indicate spouse significant . Able read , write participate interview site . Exclusion Criteria PWCBD : Other bleed disorder besides congenital hemophilia A B Eligibility criterion spouses/significant ( SSO ) participant study : A person relationship minimum 9 month PWCBD participate study . PWCBD partner must participate study . Willing participate questionnaire interview site . Exclusion criterion SSO : Biologically relate PWCBD participant ( , parent , sibling , child biologicallyrelated caregiver ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hemophilia</keyword>
	<keyword>Spouse</keyword>
	<keyword>Significant Other</keyword>
	<keyword>Quality Life</keyword>
</DOC>